# Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer

> **NCT05513144** · — · UNKNOWN · sponsor: **chenwu** · enrollment: 30 (estimated)

## Conditions studied

- Gastric Cancer
- Circulating Tumor DNA (ctDNA)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05513144
- **Lead sponsor:** chenwu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-24
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-02-28
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05513144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05513144, "Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05513144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*